Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2018 | 09-2017 | 09-2016 | 09-2015 | 09-2014 | |
| Sales | 206,625 | 102,814 | 88,268 | 160,880 | 47,741 |
| Gross Profit | 206,625 | 102,814 | 88,268 | 160,880 | 47,741 |
| Operating Expenses | 118,297 | 78,200 | 57,427 | 36,732 | 28,756 |
| Operating Income | 88,328 | 24,614 | 30,841 | 124,148 | 18,985 |
| Interest Expense | 0 | 0 | 0 | 8 | 18 |
| Other Income | 4,793 | 2,333 | 1,719 | 1,315 | 301 |
| Pre-tax Income | 93,121 | 26,947 | 32,560 | 125,455 | 19,268 |
| Income Tax | 21,165 | 9,237 | 10,894 | 46,463 | -15,170 |
| Net Income Continuous | 71,956 | 17,710 | 21,666 | 78,992 | 34,438 |
| Net Income | $71,956 | $17,710 | $21,666 | $78,992 | $34,438 |
| EPS Basic Total Ops | 3.74 | 0.93 | 1.14 | 4.23 | 1.88 |
| EPS Basic Continuous Ops | 3.74 | 0.93 | 1.14 | 4.23 | 1.88 |
| EPS Diluted Total Ops | 3.48 | 0.91 | 1.13 | 4.09 | 1.80 |
| EPS Diluted Continuous Ops | 3.48 | 0.91 | 1.13 | 4.09 | 1.80 |
| EPS Diluted Before Non-Recurring Items | 3.48 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $90,011 | $27,453 | $34,013 | $127,031 | $21,457 |